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Abstract
Emergency surgery of the small bowel represents a challenge for the surgeon, in the third millennium as well.
There is a wide number of pathologies which involve the small bowel. The present review, by analyzing the recent
and past literature, resumes the more commons. The aim of the present review is to provide the main indications
to face the principal pathologies an emergency surgeon has to face with during his daily activity.
Review
The small intestine is a complex organ with several
functions. In fact it is capable of digestion, absorption
and secretion, endocrine function and protects the inter-
nal environment against noxious ingested substances
and against luminal bacteria and their toxins. The
potential surface area available for digestion and absorp-
tion is amplified 600-times by circular mucosa folds, vil-
lus mucosal architecture and the microvillus surface of
epithelium. Although specific properties are characteris-
tic of specific segments of small bowel, like bile acid
absorption in distal ileum, maximal resections are feasi-
ble without a significant morbidity because of the com-
pensatory adaptation of remaining intestine. The small
bowel measures about 120 cm in length from pylorus to
ileocecal valve. The jejunum begins at ligament of
Treitz. Jejunum and ileum are suspended by a mobile
mesentery covered by a visceral peritoneal lining that
extends onto the external surface of the bowel to form
the serosa. Jejunum and ileum receive their blood from
the superior mesenteric artery (SMA). Although mesen-
teric arcades form a rich collateral network, occlusion of
a major branch of the SMA may result in segmental
intestinal infarction. Venous drain is via the superior
mesenteric vein, which then joins the splenic vein
behind the neck of the pancreas to form the portal vein.
Peyer’s patches are lymphoid aggregates present on the
antimesenteric border of distal ileum. Smaller follicles
are present through all small bowel. Lymphatic drainage
of intestine is abundant. Regional lymph nodes follow
the vascular arcades and then drein toward the cysterna
chyli. Jejunal and ileal wall consists of serosa, musco-
laris, submucosa and, innermost, mucosa [1].
Mechanical small bowel obstruction
Acute mechanical obstruction of the intestine is a com-
mon surgical emergency and a major cause of admission
to emergency surgery departments. Small bowel
obstruction occurs when there is an obstacle to the flow
of luminal contents caused by an extrinsic or intrinsic
encroachment on the lumen [2]. Adynamic ileus pre-
sents the same symptoms of mechanical obstruction but
the underlying problem is disordered motility. One of
the keys to management of intestinal obstruction is
early diagnosis. Particularly, accurate early recognition
of strangulation is crucial because this emergency causes
bowel ischemia, necrosis and perforation. In neonates
most common causes are atresia, midgut volvulus and
meconium ileus, in infants groin hernia, intussusception
and Meckel’s diverticulum, whereas in young adults and
adults adhesions and groin hernia [1]. In small bowel
obstruction the normal mechanisms of intestinal absorp-
tion are compromised, so an excess of fluid loss occurs.
Initially vomiting, bowel wall edema and transudation
into the peritoneal cavity are present, whereas in the
later stages venous pressure increases with consequent
bleeding into the lumen and aggravation of hypovolemia
[2]. Diagnosis is usually clinical. Main symptoms are
abdominal pain, absence of flatus or stool, nausea or
vomiting, dehydration, and abdominal distension if the
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the kind of pain suggests the level of the small bowel
obstruction. Proximal obstruction tend to present with
more frequent cramps whereas distal obstructions cause
less severe cramps with longer duration between epi-
sodes. Laboratory tests show an elevated hematocrit
because of intravascular volume loss. A significant leu-
kocytosis could indicate a strangulation or perforation.
Plain X-rays of the abdomen reveal dilatation of the
small bowel and air-fluid levels [3]. CT scan, eventually
with oral contrast, shows thed i l a t a t i o no fp r o x i m a l
bowel and the collapse of distal bowel [4,5]. Also ultra-
s o u n d sm a yb eu s e f u l[ 6 , 7 ] .T h ek e yo fm a n a g e m e n to f
small bowel obstruction is the identification of intestinal
strangulation, because mortality increases from 2 to 10
folds in such cases. Therefore an immediate surgical
repair with an eventual bowel resection is mandatory.
However, the clinical diagnosis of small bowel strangula-
tion is extremely difficult and CT scan becomes very
useful, usually on the basis of either bowel wall thicken-
ing, mesenteric edema, asymmetrical enhancement with
contrast, pneumatosis, or portal venous gas. Mortality
for small bowel obstruction has decreased during the
past 50 to 60 years from 25% to 5% [8-20]. Initial ther-
apy aims at correction of depletion of intravascular
fluids and electrolyte abnormalities. The patient should
be given nothing by mouth and nasogastric tube should
be inserted in patients with emesis. In patients with
adhesive small intestine obstruction, water-soluble con-
trast medium (Gastrografin
®) with a follow-through
s t u d yh a sn o to n l yad i a g n o s t i cb u ta l s oat h e r a p e u t i c
role, because it is safe and reduces the operative rate
and the time to resolution of obstruction, as well as the
hospital stay [21-23]. Surgical intervention is instead
mandatory for patients with a complete small bowel
obstruction with signs or symptoms indicative of stran-
gulation, perforation or those patients with simple
obstruction that has not resolved within 24 to 48 hours
of non operative treatment [23]. The surgical approach
includes adhesiolysis and resection of non viable intes-
tine. The extension of intestinal resection depends on
the purple or black discoloration of ischemic or necrotic
bowel. Viable intestine also has mesenteric arterial
pulsation and normal motility. When ischemic damage
is more limited, is sufficient adhesiolysis followed by a
10-15 minutes period of observation to allow for possi-
ble improvement in the gross appearance of the
involved segment.
The role of laparoscopy in small bowel obstruction
has still to be defined. Certainly, laparoscopy represents
a diagnostic act and sometimes has a therapeutic role
[24,25]. The major indication is small bowel obstruction
due to unique band adhesion without signs of ischemia
and necrosis. In laparoscopic procedures the first trocar
has to be positioned using Hasson’s technique for open
laparoscopy to avoid accidental bowel perforations
related to bowel distension and adhesions with the
abdominal wall. After that, two 5 mm trocars must be
introduced under vision to explore the peritoneal cavity
and find the bowel segment obstructed by the band
adhesion. If ischemic or necrotic bowel is present con-
version to open surgery may be necessary. An atrau-
matic grasp can be used to isolate the band adhesion,
which is coagulated by bipolar coagulator and then sec-
tioned with scissors. So the obstructed bowel segment is
liberated. The rate of laparotomic conversions ranges
widely from 0% to 52%, depending on patient selection
and surgical skills [24-29]. The principle reason is a dif-
ficult exposition and treatment of band adhesions due
to a reduced operating field caused by small bowel dila-
tation, multiple band adhesions, and sometimes the pre-
sence of posterior band adhesion which are more
difficult to treat laparoscopically. The predictive factors
for successful laparoscopic adhesiolysis are a number of
previous laparotomies lower than 3, a non-median pre-
vious laparotomy, appendectomy as previous surgical
treatment causing adherences, a unique band adhesion,
an early laparoscopic management (possibly within
24 hours), no signs of peritonitis and the experience of
the surgeon [24-29]. Relative contraindication are 3 or
more previous laparotomies and multiple adherences.
Finally, absolute contraindications to laparoscopic adhe-
siolysis are an abdominal film showing a remarkable
dilatation (more than 4 cm) of the small bowel, signs of
peritonitis, severe cardiovascular or respiratory co-mor-
bidities and haemostatic disease, and hemodynamic
instability. Laparotomic conversion is often related to a
higher morbidity rate, so when the predictive factors for
a successful laparoscopy are not present a primary
laparotomic access becomes necessary [25]. In any case,
early conversion is recommended to reduce postopera-
tive morbidity [25]. Many studies in literature suggest
that laparoscopic adhesiolysis in small bowel obstruction
is convenient if performed by skilled surgeons in cor-
rectly selected patients, resulting in a shorter hospital
stay with a early flatus and a early realimentation and in
a lower postoperative morbidity. Nonetheless laparo-
scopic surgery requires a longer operating time and
recurrent obstruction remains the major postoperative
risk in the management of these patients.
Crohn’s disease
Acute surgical emergencies in patients with inflamma-
tory bowel disease are infrequent but may be dangerous
for life. Crohn’s disease is an important cause of small
bowel acute surgery [1,30-32]. Ileal localization, particu-
larly terminal ileum, is the most frequent in Crohn’s dis-
ease, despite its pan-intestinal nature. Skip lesions
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induce a wide spectrum of acute surgical emergencies.
Small bowel is the main site of bleeding in Crohn’sd i s -
ease. The bleeding is often from a localized source,
caused by erosion of a blood vessel within multiple deep
ulcerations that extend into bowel wall. Severe hemor-
rhage is rare and requires surgery [33,31]. Other surgical
indications include a bleeding who doesn’ts l o wa f t e r4
to 6 units of blood and recurrent hemorrhage [1].
Because of segmental disease, the best approach is to
localize the source of bleeding preoperatively. The
patient is stabilized and a nasogastric tube is inserted.
Gastroscopy, angiography and the use of labeled red
cells scan help localizing the hemorrhage. If the site of
bleeding is identified in small bowel, resection and pri-
mary anastomosis is the gold standard surgical treat-
ment. Perforation is another surgical emergency in
patients with Crohn’s disease [33]. It occurs in 1% to 3%
of cases. The transmural nature of Crohn’s disease cre-
ates inflammatory adhesions between bowel and local
structures, so the perforation is often sealed. If perfora-
tion is suspected, the patient must be resuscitated and
prepared to surgery. Jejunal and ileal perforations
require resection and primary anastomosis if possible
[1,33,31,32]. Otherwise resection with intestinal diver-
sion is necessary. More than 25% of patients undergoing
surgery for Crohn’s disease will have either an intra-
abdominal mass or abscess, and 40% of these have an
associated fistula [31]. An intra-abdominal mass may be
the consequence of distended loops of proximal bowel
caused by distant strictures, thinning of diseased loops,
phlegmon with associated fistulae, or an abscess cavity
[34,35]. The cause of abdominal abscesses is the trans-
mural ulceration of the diseased bowel, which creates
secondary adhesions to adjacent structures resulting in
intraperitoneal, retroperitoneal or rarely intramesenteric
abscesses. Progresses in interventional radiological tech-
niques have increased, facilitating an improvement in
patient’s general conditions before the eventual surgical
repair. If general conditions are favorable, in selected
cases of perforation of the jejunum or ileum without
abscess and early intervention, primary reconstruction is
possible. However, having to do with intestinal perfora-
tion and abscessed small bowel, resection with fecal
diversion is the gold standard surgical strategy. Intestinal
obstruction is the main complication requiring surgical
intervention in Crohn’s disease, affecting 35% to 54% of
patients [33,36,37]. Because of transmural nature of dis-
ease process, obstruction can be the consequence of an
acute and active inflammation superimposing on a ste-
notic portion of the bowel. Fibrosis and scarring with
stricture formation, and mass effect of an adjacent
abscess or phlegmon are common events in Crohn’s dis-
ease. Although it is rare, a complete or near complete
intestinal obstruction not responsive to medical therapy
requires a surgical treatment [38,39]. The treatment
may be a resection or a strictureplasty depending on
localization of the disease [34,31]. Strictureplasty is a
safe and efficacy procedure for small bowel Crohn’sd i s -
ease in the long term [33,40]. Strictureplasty should be
reserved only for fibrotic stricture with inactive disease
and only if resection is inappropriate [33,41]. Resection
has been for a long time the mainstay treatment of
Crohn’s disease associated with small bowel strictures.
However, recurrence rates are high and most of patients
need multiple resections. So, the concern of short-bowel
syndrome led to the use of bowel-sparing procedures.
Principle indications for strictureplasty are multiple
strictures over large length of bowel, previous resections,
short bowel syndrome and strictures associated with
phlegmon or fistula [34,31,42]. Contraindications
include preoperative malnutrition (albumin < 2 g/dL),
perforation, multiple strictures over short length of
bowel, stricture short distant from area of resection and
bleeding from planned strictureplasty site [34,31,42].
Several strictureplasty techniques have been described
and the choice depends on the length of the stricture
[34]. Short strictures are treated with Heineke-Mikulicz
strictureplasty. A longitudinal enterotomy is realized
over the stricture on the antimesenteric border of the
bowel and extended 1 to 2 cm onto either side of nor-
mal bowel. The enterotomy can be realized using bistury
or cautery. Then, the enterotomy is closed transversally
with a interrupted, sieromuscolar, absorbable suture.
The closure should be performed in one or two layers
and must be tension-free. The Finney strictureplasty is
used for strictures of intermediate length. First of all, a
stay suture is localized in the midpoint of the stricture.
The enterotomy is performed throught the stricture,
again extending 1 to 2 cm onto normal bowel. Then
strictured segment is folded onto itself to realize a “U”
and another stay suture is localized in the normal side
of bowel to keep the “U” in place. The posterior edges
are sutured in a continuous way using an absorbable
suture. In the end, the anterior edges are closed with a
interrupted non absorbable suture. In 1996, Michelassi
introduced the side-to-side isoperistaltic strictureplasty
for long strictures, usually greater than 20 to 25 cm, and
multiple strictures over a limited area [43]. In this tech-
nique, the sctrictured bowel is lifted up and his mesen-
tery is divided at the midpoint. Then the diseased bowel
is divided between atraumatic bowel clamps at the mid-
point of the stricture. The proximal end of the cut
bowel is brought over the distal end in a side-to-side
way. The two loops are approached with a single-layer,
interrupted, non absorbable suture. Then enterotomy is
realized longitudinally for the length of the stricture.
The ends of bowel are spatulated to avoid blind ends.
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suture is placed and continued anteriorly. This anterior
layer is then followed by a layer of interrupted, non
absorbable, sieromuscolar suture. Markedly thickened
bowel loops, thickened and friable mesentery, inflamma-
tory phlegoms, fistula, abscesses and adhesions from
previous surgery represent a surgical challenge to the
laparoscopic approach. Many studies in literature sug-
gest that laparoscopic approach is feasible and safe in
terminal ileal Crohn’s disease, because it offers advan-
tages in terms of pulmonary function, length of hospital
stay, duration of postoperative ileus, cosmesis, post-
operative small bowel obstruction, and early postopera-
tive complications. Furthermore laparoscopy reduces the
hospitalization costs and improves patient satisfaction
[44][32][45-47].
Small bowel neoplasms
T u m o r so ft h es m a l lb o w e la r eav e r yr a r ee n t i t y ,
accounting for only 1% of all gastrointestinal neoplasms
and 0,3% of all tumors [48-51]. The most common
modes of presentation are intestinal obstruction and
occult gastrointestinal hemorrhage. Occasionally, the
presentation involves the development of a palpable but
otherwise asymptomatic mass, whereas perforation and
gross bleeding are rare. Small bowel tumors are usually
located in the proximal small bowel, with the exception
of adenocarcinoma in the contest of ileal Crohn’sd i s -
ease and NETs [1,52,50,51,53,54].
Adenomas are the most common benign tumors of
jejunum and ileum. Their histological subtype are either
tubular adenomas with low malignant potential or vil-
lous adenomas with high malignant potential. Lipomas
a r em o r ef r e q u e n ti nt h ei l e u m ,h a v en om a l i g n a n t
potential and do not require a surgical excision unless
symptomatic.
Malignant neoplasm present similarly to benign
lesions. Diagnosis is often delayed conducing to
advanced tumors, for whom surgical resection is rarely
curative [1,55-57]. Adenocarcinomas represent 50% of
all small bowel malignancies [1]. Most lesions are
located in the proximal bowel, except in the setting of
Crohn’s disease in which most are ileal [1,57,58]. Resec-
tion is the best treatment but overall the prognosis is
poor due to late presentation in most patients (15% to
35% 5-year survival) [1,58]. Lymphomas represent 10%
to 20% of small bowel malignant tumors. The ileum is
the most common site of involvement because of the
greatest amount of gut-associated lymphoid tissue [1].
Primary small-bowel lymphoma is the most common
extranodal form of lymphoma. Most are non-Hodgkin’s
lymphomas and predominantly B-cells in origin [59-62].
Patients commonly present with fatigue, weight loss
and abdominal pain, whereas perforation, bleeding,
obstruction or intussusceptions are less frequent. Treat-
ment in such emergent cases is surgical and consists in
resection along with a wedge of mesentery. Adjuvant
therapy is recommended for patients with positive mar-
gins. Survival for completely resected intestinal lympho-
mas is about 50% [1].
Gastrointestinal stromal tumors (GISTs) can arise any-
where in the gastrointestinal tract: 50-70% in the sto-
mach, 20-40% in the small bowel, 5-15% in the colon
and rectum, 5% in the esophagus and the omentum,
and rarely in the mesentery or retroperitoneum
[52,63-67]. They account for approximately 0,1% to 3%
of all gastrointestinal neoplasms. GISTs are more com-
mon between the ages of 40 and 70, without sex differ-
ence. GISTs are thought to arise from the intestinal
cells of Cajal, which are intestinal pacemaker cells that
regulate peristalsis. Bleeding occurs in almost 50% of
GISTs. Approximately 35% of patients present with
abdominal mass causing or not symptoms, and 20% of
patients have abdominal pain. When tumors arise from
the small bowel slow bleeding and mild obstructive
symptoms can go undiagnosed for a long. GISTs usually
do not metastatize beyond the gastrointestinal tract and
the liver [68,69]. Prognosis varies and depends on the
site of GIST, origin, mitotic index, and size. Small intes-
tine GISTs are more aggressive and have a worst prog-
nosis [70,71]. When GIST presents as an emergency,
surgery is the mainstay. In cases where is feasible and
the risk-benefit balance is favourable, the goal is to com-
pletely resect the primary tumor, surrounding normal
tissue, and adjacent organs if they are affected with
GIST. Because of their fragility, surgeon must handle
GIST with great care to avoid tumor rupture. GISTs
are resistant to chemotherapy and radiotherapy [52].
However targeted chemotherapy has dramatically
increased the outcome of GISTs treatment, either of
non-resectable GISTs.
Gastroenteropancreatic neuroendocrine tumors (GEP-
NET) are a heterogeneous group of uncommon malig-
nancies occurring in the gastrointestinal system. The
incidence of GEP-NET is 2 to 3 per 100,000 people per
year [72,73]. Symptoms depend on the tumor cells of
origin and the effects of secreted substances. However,
patients may seek medical care when gastrointestinal
emergencies occur. Imaging studies help to make a
diagnosis and include ultrasounds, CT, RMI, PET, and
radiolabeled somatostatin receptor scintigraphy
(OctreoScan) [72]. Small bowel NETs are the most com-
mon and occur more frequently in ileum than in jeju-
num. Unfortunately 60% of these neoplasms are
diagnosed when distant metastasis to lymph nodes and
liver have occurred. 5-years survival rate is 60%, but
drops to 30% if liver metastasis are present [72,74].
About 10% of patients with metastatic ileal NETs have
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sents with a massive gastrointestinal bleeding, secondary
to sclerosis of vasa recta, due to hypersecretion of sero-
tonin. Sclerosis of arterial vessels may also provoke a
bowel ischemia. Otherwise, endo-luminal growth of the
cancer or mesenteric fibrosis create the condition for an
intestinal obstruction. In such cases surgical treatment
becomes emergent.
Intestinal involvement of metastatic cancer is com-
mon, mostly in the form of peritoneal carcinomatosis.
Because of the continuous recirculation of peritoneal
fluid through all the abdomino-pelvic cavity, small
bowel is an elective site for peritoneal metastasis. All
abdominal tumors can lead to peritoneal carcinomatosis,
particularly colorectal cancer, ovarian cancer, gastric
cancer, and primitive peritoneal neoplasms. The diagno-
sis of peritoneal secondary tumors as the cause of small
bowel obstruction is often difficult. Obstruction in these
circumstances never resolves by conservative treatment
and surgical intervention is almost always indicated.
Although peritoneal carcinomatosis has been for a long
considered a terminal condition, in the latest years a
new curative option consisting of extensive cytoreduc-
tive surgery (CRS) and hyperthermic intraperitoneal
chemotherapy (HIPEC) has emerged for accurately
selected patients [75-78].
Meckel’s diverticulum and acquired jejunoileal
diverticulosis
Meckel’s diverticulum is the most common congenital
malformation of the gastrointestinal tract, interesting 2%
to 4% of population [79]. It is a true diverticulum due
to the persistence of omphalo-mesenteric duct, which
connects in fetal life the yolk sac to the intestinal tract
and usually obliterates in the 5
th to 7
th week of life. It is
localized on anti-mesenteric border of the distal ileum,
usually 30-40 cm far from the ileo-cecal valve [1,79,80].
Meckel’s diverticulum is lined mainly by the typical ileal
mucosa as in the adjacent small bowel. However, in 20%
of cases ectopic gastric mucosa may be found. Globally
the incidence of complications ranges from 4% to 16%
[79]. Although there is no sex differences in the inci-
dence of Meckel’s diverticulum, its complications are
3-4 times more frequent in males. Meckel’s diverticulum
is the most common cause of bleeding in the pediatric
age group. The risk of complications decreases with
increasing age [79,80]. The most frequent complications
in adults are obstruction due to the intussusceptions or
adhesive band, ulceration, diverticulitis and perforation
[79,1,80]. Preoperative diagnosis of symptomatic Meck-
el’s diverticulum is difficult, especially in patients with
symptoms other than bleeding. In doubtful cases,
laparoscopy is the preferred diagnostic modality. How-
ever, technetium 99-m pertechnate scan is the most
common and accurate non-invasive investigation,
although it is specific to ectopic gastric mucosa, not to
Meckel’s diverticulum [80]. In the presence of symp-
toms, the treatment of choice is the surgical resection.
This can be achieved either by diverticulectomy or by
the segmental bowel resection and anastomosis, espe-
cially when there is palpable ectopic tissue, intestinal
ischemia or perforation [1,79].
Acquired jejunoileal diverticulosis (JID) is a rare entity
often asymptomatic and treated conservatively. How-
ever, JID can develop a number of complications requir-
ing acute surgical care [81-83]. The incidence of JID
increases with age, with the peak occurring in the sixth
and seventh decades of life. The etiology is unclear, but
the most commonly accepted is the one related to the
acquired mechanism. A motor dysfunction or jejuno-
ileal dyskinesia leads to an intraluminal pressures
increase. As a result, mucosa and submucosa herniate
through the weakest site of the muscolaris of the small
bowel, which is on the mesenteric border where paired
vasa recta penetrate the bowel wall [81,84]. So, these are
pseudodiverticula. About 55% to 80% of diverticula
occur in the jejunum, 15% to 38% in the ileum and 5%
to 7% in both [85,86]. Two-third of patients have multi-
ple diverticula and therefore a major risk of developing
complications [85]. Although the diagnosis of JID is
often accidentally, 10% to 19% of patients with JID pre-
sent with acute and emergent complications. Diverticuli-
tis occurs in 2% to 6% of patients and can progress to
gangrene with full-thickness necrosis and perforation,
which has a mortality rate as high as 40%. Perforation
presents either with localized or generalized peritonitis,
and the mainstay of treatment includes resection of the
affected segment and primary anastomosis. Obstruction
occurs in 2% to 4% of patients, due to adhesions, intus-
susceptions, volvolus, extrinsic compression from a
fluid-filled diverticulum, enteroliths [81,85]. Bleeding
complications interest 3% to 8% of patients with JID.
T h ep r o x i m i t yo ft h en e c ko ft h ed i v e r t i c u l at ot h e
mesenteric vessel is responsible for bleeding resulting
from erosion and ulceration of the mucosa. In case of
massive hemorrhage, surgical resection of the affected
bowel and anastomosis is mandatory [81,86].
Acute mesenteric ischemia
Acute mesenteric ischemia (AMI) is an uncommon
event, according for less than 1 case in every 1000 hos-
pital admissions. Females are affected with three times
the frequency of males and patients are usually between
the age of 60 and 70 with several comorbidities [81].
Arterial embolism is the major cause of AMI, according
for 40% to 50% of cases [87]. Most events are throm-
boembolic and arise from a cardiac source [87]. Throm-
boemboli tend to lodge in proximal superior mesenteric
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minority (15%) may lodge at the SMA origin, whereas
about 50% lodge distal to the middle colic artery
[88,89]. In this case, proximal intestine and ascending
colon are spared. Instead atheroembolic emboli tend to
be smaller and to lodge in the distal SMA, therefore
affecting bowel perfusion less often and in more loca-
lized areas. Acute arterial thrombosis superimposed on
preexisting severe atherosclerotic disease accounts for
25% to 30% of all cases [87,90]. Bowel infarction is more
insidious because extensive collateral are able to main-
tain viability until there is a final closure of critically ste-
notic vessel or collateral. The infarction is more
confluent, without sparing of small bowel or right colon
circulation, because SMA is often interested at its origin.
A c u t ep r e s e n t a t i o no nah i s t o r yo fc r o n i cm e s e n t e r i c
ischemia is usual. The small bowel is able to tolerate a
significant reduction in blood flow. However, when the
ischemia is prolonged, it leads to disruption of the
intestinal mucosa. Patients present abdominal pain.
SMA embolism has the more rapid clinical decline due
to the lack of collateral vessels. The advent of high-qual-
ity computed tomography angiography has supplanted
angiography to make the diagnosis of AMI [91,92].
However angiography still plays an important role not
only in the diagnosis but also in the treatment [93].
Diagnostic laparoscopy is not widely accepted because it
may miss areas of nonviable bowel. After initial resusci-
tation and stabilization of the patient, surgery is
required for all patients who have evidence of threa-
tened bowel. Surgeon should proceed with revasculariza-
tion before resecting any intestine unless faced with an
area of frank necrosis or perforation or peritoneal soi-
lage. In such cases resection of the affected bowel with-
out reanastomosis and containment of the spillage
should be rapidly achieved before revascularization. In
few patients with massive bowel necrosis revasculariza-
tion can be avoided.
Miscellaneous conditions
Pneumatosis intestinalis is the presence of gas within
the abdominal wall of the bowel. Benign pneumatosis
is an incidental finding without any underlying pathol-
ogy. Conversely, when pneumatosis intestinalis is the
result of primary intestinal pathology, urgent surgery is
mandatory. The intramural gas can result from necro-
sis caused by ischemia, infarction, neutropenic colitis,
volvulus, and necrotizing enterocolitis. Benign pneu-
matosis instead is related to a pulmonary source in
patients with COPD, asthma, or cystic fibrosis. The
intrathoracic air can dissect via the retroperitoneum
and into the intestinal wall. It is generally accepted
that patients with pneumatosis intestinalis associated
with either bowel obstruction or ischemia usually
require urgent surgery [94]. The presence of air within
the bowel wall itself does not mandate resection,
because the air may have tracked from another site
within the bowel, such a segment of ischemia or
necrosis. In such a case, only the ischemic bowel seg-
ment must be resected [1].
Small bowel ulceration is usually the result of ingested
medications like enteric-coated potassium chloride, non-
steroidal anti-inflammatory drugs, and corticosteroids
[1,95]. Clinical presentation is usually an intermittent
small bowel obstruction. Preoperative localization of
these lesions is difficult, and is frequently necessary the
palpation of the small bowel at laparotomy or an intrao-
perative endoscopy. The treatment of small bowel
ulceration is surgical resection. Suture repair after the
perforation of small bowel ulceration presents a high
rate of complications. Recurrence after resection is rare.
The accidental or intentional ingestion of foreign
bodies is not rarely observed in emergency departments.
Although intestinal perforation is rare, the development
of abdominal pain with tenderness and leukocytosis
strongly suggests a perforation. In case of perforation,
surgical resection is required, because antibiotic treat-
ment is associated with chronic infection or stricture
formation.
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